Cutaneous nontuberculous mycobacteria infections: A retrospective case series of 78 patients from the Texas Gulf Coast region - 15/08/19
Abstract |
Background |
The incidence of cutaneous nontuberculous mycobacteria (NTM) infections is increasing. These infections are a diagnostic and therapeutic challenge.
Objective |
We investigated the clinical features, diagnosis, and management of cutaneous NTM infections.
Methods |
A retrospective case series studied 78 patients from a Gulf Coast tertiary referral center diagnosed with cutaneous NTM infection by culture or stain of a skin biopsy specimen.
Results |
A history of trauma, procedure, or environmental exposure was common. The mean time between the initial evaluation and diagnosis was 12 weeks. Only 15% of acid-fast bacillus-positive cultures had a positive acid-fast bacillus smear, and only 43% of those accompanied by skin biopsy specimen had a positive Fite stain. Immunosuppressed patients were more likely to have a positive Fite stain. Treatment included surgery and multiple antibiotics. Immunosuppressed patients and Mycobacterium abscessus group infections were more likely to have persistent disease.
Limitations |
M chelonae and M abscessus isolates were indistinguishable and therefore were reported together. Five cases were not confirmed by culture.
Conclusions |
Even with clinical suspicion, the diagnosis of NTM infection can be difficult. Results of acid-fast bacillus smears and special stains are frequently negative. Antibiotic resistance is common. Multidrug treatment is often required, and surgical therapy may be needed.
Le texte complet de cet article est disponible en PDF.Key words : acid-fast bacilli, antibiotic susceptibility, atypical mycobacteria, case series, cutaneous, diagnosis, nontuberculous mycobacteria, risk factors, skin, treatment
Abbreviations used : AFB, NTM, RGM, rRNA
Plan
Funding sources: None |
|
Conflicts of interest: None disclosed. |
|
Presented as a poster at the 2018 American Academy of Dermatology Annual Meeting, San Diego, California, February 16-20, 2018. |
Vol 81 - N° 3
P. 730-739 - septembre 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?